Literature DB >> 19764023

Confirmation of TFAP2A gene involvement in branchio-oculo-facial syndrome (BOFS) and report of temporal bone anomalies.

C Stoetzel1, S Riehm, V Bennouna Greene, V Pelletier, J Vigneron, B Leheup, V Marion, S Hellé, J M Danse, C Thibault, L Moulinier, F Veillon, H Dollfus.   

Abstract

Branchio-oculo-facial syndrome (BOFS) is an autosomal-dominant condition characterized by three main features, respectively: branchial defects, ocular anomalies, and craniofacial defects including cleft lip and/or palate (CL/P). We report on one family with three affected, and two sporadic cases that have been found to carry missense mutations in the newly reported BOFS gene: TFAP2A. This report confirms the involvement of this transcription factor in this developmental syndrome with clinical variability. Moreover, we present CT scan temporal bone anomalies in the familial cases, related to branchial arch defects, highlighting the importance of radiological investigations for differential diagnosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764023     DOI: 10.1002/ajmg.a.33015

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  9 in total

1.  FOXD1 Duplication Causes Branchial Defects and Interacts with the TFAP2A Gene Implicated in the Branchio-Oculo-Facial Syndrome in Causing Eye Effects in Zebrafish.

Authors:  I Balikova; K Devriendt; J-P Fryns; J R Vermeesch
Journal:  Mol Syndromol       Date:  2011-05-18

2.  Histone demethylase KDM5B collaborates with TFAP2C and Myc to repress the cell cycle inhibitor p21(cip) (CDKN1A).

Authors:  Ping-Pui Wong; Fabrizio Miranda; KaYi V Chan; Chiara Berlato; Helen C Hurst; Angelo G Scibetta
Journal:  Mol Cell Biol       Date:  2012-02-27       Impact factor: 4.272

3.  Genetic Dissection of a Supergene Implicates Tfap2a in Craniofacial Evolution of Threespine Sticklebacks.

Authors:  Priscilla A Erickson; Jiyeon Baek; James C Hart; Phillip A Cleves; Craig T Miller
Journal:  Genetics       Date:  2018-03-28       Impact factor: 4.562

Review 4.  Cardiac Neural Crest Cells: Their Rhombomeric Specification, Migration, and Association with Heart and Great Vessel Anomalies.

Authors:  Olivier Schussler; Lara Gharibeh; Parmeseeven Mootoosamy; Nicolas Murith; Vannary Tien; Anne-Laure Rougemont; Tornike Sologashvili; Erik Suuronen; Yves Lecarpentier; Marc Ruel
Journal:  Cell Mol Neurobiol       Date:  2020-05-13       Impact factor: 5.046

Review 5.  Ocular manifestations of branchio-oculo-facial syndrome: report of a novel mutation and review of the literature.

Authors:  M S Al-Dosari; M Almazyad; L Al-Ebdi; J Y Mohamed; Saad Al-Dahmash; Hassan Al-Dhibi; Eman Al-Kahtani; Shahira Al-Turkmani; Hisham Alkuraya; B D Hall; F S Alkuraya
Journal:  Mol Vis       Date:  2010-05-08       Impact factor: 2.367

6.  AP-2alpha knockout mice exhibit optic cup patterning defects and failure of optic stalk morphogenesis.

Authors:  Erin A Bassett; Trevor Williams; Amanda L Zacharias; Philip J Gage; Sabine Fuhrmann; Judith A West-Mays
Journal:  Hum Mol Genet       Date:  2010-02-11       Impact factor: 6.150

7.  Analysis of TFAP2A mutations in Branchio-Oculo-Facial Syndrome indicates functional complexity within the AP-2α DNA-binding domain.

Authors:  Hong Li; Ryan Sheridan; Trevor Williams
Journal:  Hum Mol Genet       Date:  2013-04-10       Impact factor: 6.150

8.  Tfap2a-dependent changes in mouse facial morphology result in clefting that can be ameliorated by a reduction in Fgf8 gene dosage.

Authors:  Rebecca M Green; Weiguo Feng; Tzulip Phang; Jennifer L Fish; Hong Li; Richard A Spritz; Ralph S Marcucio; Joan Hooper; Heather Jamniczky; Benedikt Hallgrímsson; Trevor Williams
Journal:  Dis Model Mech       Date:  2014-11-07       Impact factor: 5.758

9.  Gene-Expression Analysis Identifies IGFBP2 Dysregulation in Dental Pulp Cells From Human Cleidocranial Dysplasia.

Authors:  Stephen L Greene; Olga Mamaeva; David K Crossman; Changming Lu; Mary MacDougall
Journal:  Front Genet       Date:  2018-05-23       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.